The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The combination of EGFR-TKIs and anlotinib as a first-line therapy for EGFR-mutant advanced non-small cell lung cancer: A multicenter, single-arm, phase II clinical trial.
 
Zhiyong He
No Relationships to Disclose
 
Jinghui Lin
No Relationships to Disclose
 
Yueming He
No Relationships to Disclose
 
Jing Zhang
No Relationships to Disclose
 
Dongyong Yang
No Relationships to Disclose
 
Wenbin Qiu
No Relationships to Disclose
 
Jinhuo Lai
No Relationships to Disclose
 
Xi Chen
No Relationships to Disclose
 
Wenzheng Fang
No Relationships to Disclose
 
Feng Ye
No Relationships to Disclose
 
Tianwen Xu
No Relationships to Disclose
 
Huita Wu
No Relationships to Disclose
 
Dongfa Qiu
No Relationships to Disclose
 
Wujin Chen
No Relationships to Disclose
 
Lifang Cai
No Relationships to Disclose
 
Shengchi Chen
No Relationships to Disclose
 
Qunying Lin
No Relationships to Disclose
 
Li Lin
No Relationships to Disclose